The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice.
|
| Abstract |
The purpose of this study was to investigate the relationship between pharmacokinetic (PK) parameters of intravenous (IV) peramivir and in vivo antiviral activity pharmacodynamic (PD) outcomes in a mouse model of influenza virus infection. Peramivir was administrated to mice in three dosing schedules; once, twice and four times after infection of A/WS/33 (H1N1). The survival rate at day 14 after virus infection was employed as the antiviral activity outcome for analysis. The relationship between day 14 survival and PK parameters, including area under the concentration-time curve (AUC), maximum concentration (Cmax) and time that drug concentration exceeds IC95 (T(>IC95)), was estimated using a logistic regression model, and model fitness was evaluated by calculation of the Akaike information criterion (AIC) index. The AIC indices of AUC, Cmax and T(>IC95) were about 114, 151 and 124, respectively. The AIC of AUC and T(>IC95) were smaller than that of Cmax. Therefore, both AUC and T(>IC95) were the PK parameters that correlated best with the antiviral activity of peramivir IV against influenza virus infection in mice.
|
|---|---|
| Authors | Makoto Kodama, Ryu Yoshida, Takahiro Hasegawa, Masaaki Izawa, Mitsutaka Kitano, Kaoru Baba, Takeshi Noshi, Takahiro Seki, Kenichi Okazaki, Masakatsu Tsuji, Takushi Kanazu, Hiroshi Kamimori, Tomoyuki Homma, Masanori Kobayashi, Yoshihiro Sakoda, Hiroshi Kida, Akihiko Sato, Yoshinori Yamano |
| Journal | Antiviral research (Antiviral Res) Vol. 109 Pg. 110-5 (Sep 2014) ISSN: 1872-9096 [Electronic] Netherlands |
| PMID | 24997412 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Copyright | Copyright © 2014 Elsevier B.V. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!